InventHelp Inventor Develops New Self-Defense Device (RKH-846)

“I wanted to create a non-lethal means of disabling an assailant or an attacker to give time for a victim to get away,” said an inventor, from Christiansburg, Va., “so I invented the SANDBOMB. My design would cause significant discomfort while also marking the assailant, so it is easier for law enforcement to find them.” […]

Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas

The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines Company plans to create 4,615 manufacturing and construction jobs Eli Lilly and Company (NYSE: LLY) announced today that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston,

Nova Compression Bolsters Growth Strategy with a $325MM Capital Raise, Including a Structured Equity Commitment from OIC and ABL from J.P. Morgan

Nova Compression, LLC (“Nova” or the “Company”), a leading provider of contract compression infrastructure, announced the closing of a $105MM Structured Equity commitment from OIC LP (“OIC”). OIC's investment is complemented by a new asset-based loan (ABL) facility led by J.P. Morgan,with participation from Bank OZK, First Citizens Bank, and Sunflower Bank,and the continued support

Now Accepting Reservations: An Immersive Journey Through Vibrant Culture, Adventure and Luxury at Four Seasons Resort and Residences Puerto Rico

Newly enhanced and refurbished, one of the Caribbean's best resort locations introduces an expanded collection of sea and land resort experiences in a natural oceanfront setting With its opening just weeks away, Four Seasons Resort and Residences Puerto Rico is now accepting reservations for arrivals beginning November 20, 2025 – just in time for sun-kissed

Hearing Notice – CIRO to Hold an Appearance in the Matter of Teymur Englesby and Cale Nishimura

Following a decision of the British Columbia Securities Commission (BCSC) in the matter of Teymur Englesby and Cale Nishimura, an appearance will be held before a hearing panel of the Canadian Investment Regulatory Organization (CIRO) pursuant to the Investment Dealer and Partially Consolidated Rules. The hearing is open to the public unless the panel orders

Former CFO settles with the ASC for fraud and materially misleading statements

The Alberta Securities Commission (ASC) has concluded a Settlement Agreement and Undertaking (Settlement Agreement) with Colin Garfield Wagner (Wagner) for fraud and making false and materially misleading statements between October 2019 and February 2021, while he was the chief financial officer (CFO) of a reporting issuer formerly known as Target Capital Inc. (Target). Target's shares

Kruger PRO’s all-new Titan(R) Wipers & Cloths are Made To Perform(TM)

TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) — Kruger Products, Canada's leading tissue manufacturer, is proud to introduce Titan(R) Wipers & Cloths to its away-from-home portfolio, Kruger PRO. Replacing the legacy WORKS(R) brand, Titan is designed to meet the evolving needs of customers seeking high-performance solutions in the wiper and cloth category. With a bold new

Canterra Minerals Intersects 16.0 metres of 1.72% Copper Equivalent at Clementine Prospect, 4 km Northwest of Past-Producing Buchans Mine

(TSX-V:CTM),(OTC US:CTMCF),(Other OTC:CTMCF),(Frankfurt:DXZB), VANCOUVER, British Columbia, Sept. 23, 2025 (GLOBE NEWSWIRE) — Canterra Minerals Corporation (TSXV:CTM) (OTCQB: CTMCF) (FSE:DXZB) (“Canterra” or the “Company”) is pleased to announce its first drill results from the Clementine Prospect, part of its 100% owned Buchans Project in the Central Newfoundland Mining District. The Buchans Project is located 50 kilometres

TGF-B Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

TGF-B Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight The TGF-B inhibitors market is gaining momentum due to their ability to address significant unmet needs in oncology and fibrosis, where existing therapies often show limited effectiveness. The market is expected to surge with the launch of

Kruger PRO’s all-new Titan(R) Wipers & Cloths are Made To Perform(TM)

Kruger PRO's all-new Titan(R) Wipers & Cloths are Made To Perform(TM) New wipers & cloths brand delivers a range of high-performance products to tackle even the most demanding tasks GlobeNewswire September 23, 2025 TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) — Kruger Products, Canada's leading tissue manufacturer, is proud to introduce Titan(R) Wipers & Cloths to

Scroll to Top